Mind Matters Natural and Artificial Intelligence News and Analysis

TagBiotechnology

3d-rendering-of-human-cell-or-embryonic-stem-cell-microscope-background-stockpack-adobe-stock
3d rendering of Human cell or Embryonic stem cell microscope background.

Scientists Close to Creating Human Embryos from Stem Cells

The “anything goes” ethical peril in biotechnology is all too real

During the great embryonic-stem-cell debate in the early 2000s, I personally witnessed scientists blatantly mislead legislators about biotech issues such as cloning, adult stem cells, and the biological nature of embryos in order to gain funding and/or resist regulations. It was an effective, but disgraceful, tactic that disrespected the democratic process about crucial issues of morality and public policy. Now, with the creation of human “synthetic embryos,” aka, “embryo models, or “embryo replicas,” which are constructed with pluripotent stem cells, I hope we are not slipping back into those bad old days of mendacity. But I worry. A recent story about the breakthrough in Science News contains an incomplete description about human embryology that impacts the ethical stakes about what is being Read More ›

young-sample-plant-growing-in-test-tube-biotechnology-research-concept-stockpack-adobe-stock
young sample plant growing in test tube , biotechnology research concept

What Biotech Innovations Can Help Us Live Longer, Healthier?

Jay Richards interviews venture capitalist Matt McIlwain, whose firm invests in new tech on current promising new directions

At COSM 2021, business prof Jay Richards interviewed venture capitalist Matt McIlwain, CEO of the Madrona Group, which invests in a wide range of promising software applications: McIlwain chaired a panel on innovations in biotech, “Killing Disease and Living Longer” on November 11, 2021: Matt Mcilwain (Moderator) — Managing Director, Madrona Venture GroupStephen C. Meyer — Director, Center for Science and CultureJim Tour — T.t. and W.f. Chao Professor of Chemistry, Rice UniversityMatthew Scholz — CEO, Oisin Biotechnologies Casey Luskin offers an account of McIlwain’s 2021 panel at “Manipulating molecules: Combining info + nano for better medicine”: Yesterday at COSM 2021, philosopher of science Stephen Meyer, synthetic organic chemist James Tour, and biotech entrepreneur Matthew Scholz looked at how nanotechnology Read More ›